FDA Requires Chantix To Have Mental Health Warning
Save Email Print
FDA Requires Chantix To Have Mental Health Warning
The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.
Reporter: Associated Press
Email Address: news@kake.com
width:200 and height: 150 and picwidth: 200 and pciheight: 150
Post Your Comments
First Name:
Location:
Enter Comments: characters left
Email (optional):
By posting this comment I have read and agree to the Terms of Use and Privacy Policy:
You must agree to the Terms of Service to continue.
Read Comments
Comments are posted from viewers like you and do not always reflect the views of this station.
Posted by: Anonymous on Jul 1, 2009 at 12:48 PM

Imagine that people who try and quit smoking are depressed or want to kill themselves, it's call drug with draws.